|
|||||
|
|
Non-alcoholic fatty liver disease (NAFLD) models in drug discovery |
|
| Authors: | Banumathi K Cole Ryan E Feaver Brian R Wamhoff |
| Institution: | HemoShear Therapeutics, Charlottesville, VA USA |
| Abstract: | |
| Keywords: | Non-alcoholic fatty liver disease (NAFLD) non-alcoholic steatohepatitis (NASH) organotypic preclinical steatosis inflammation fibrosis hepatocyte hepatic stellate cell |